Shinan Wu

13PUBLICATIONS
21CO-AUTHORS
MortalityPharmacology and pharmaceutical sciences not elsewhere classifiedPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 25, 2026
Changing Epidemiology of Refractive Disorders in the Western Pacific Region, 1990-2023: Evidence From the Global Burden of Disease Study 2023.

|Oct 10, 2025
Drug-related retinal detachment pharmacovigilance signals in the real world: evidence from the FDA Adverse Event Reporting System.

Xiao-Dong Chen, Kun-Hong Xiao, Shi-Nan Wu

|Sep 25, 2025
Real-world large sample evaluation of drug-related blepharoptosis: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database.

Kunhong Xiao, Xiaodong Chen, Shinan Wu

|Dec 23, 2024
Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database.

Rongqiang Liu, Yukai Chen, Shi-Nan Wu

|Oct 26, 2024
Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database.

Shi-Nan Wu, Xiao-Dong Chen, Dan Yan

|Oct 21, 2024
Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database.

Shi-Nan Wu, Caihong Huang, Yu-Qian Wang

Pageof 3

Frequent Collaborators

5 joint publications

Yi Shao

1 joint publications

Meng-Yao Zhang

1 joint publications

Hui-Ye Shu

1 joint publications

Rong-Bin Liang